13F Holdings
中文EN

SYK STRYKER CORP

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 310764 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY7.9%
TTM net income YoY23.1%
TTM EPS YoY23.4%
Revenue 3-yr CAGR9.8%
Net income 3-yr CAGR11.9%

Margins

Gross margin65.3%
Operating margin20.7%
Net margin13.8%
FCF margin17.4%
EBITDA margin26.8%

Returns

ROE16.0%
ROA7.7%
ROIC (approx.)11.0%
Asset turnover0.56x

Leverage & solvency

Liabilities / assets50.4%
Debt / equity0.64x
Current ratio2.18x
Interest coverage9.27x

Cash quality & payout

Operating cash flow / net income1.50x
Accruals ratio-3.9%
Payout ratio36.8%
Capex / revenue3.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$25.12B$22.59B$20.50B$18.45B$17.11B
Cost of revenue$9.05B$8.15B$7.44B$6.87B$6.14B
Gross profit$16.07B$14.44B$13.06B$11.58B$10.97B
R&D expense$1.62B$1.47B$1.39B$1.45B$1.24B
SG&A expense$8.65B$7.68B$7.11B$6.39B$6.43B
Operating income$4.89B$3.69B$3.89B$2.84B$2.58B
Interest expense$607.00M$409.00M$363.00M$337.00M$337.00M
Pretax income$4.51B$3.49B$3.67B$2.68B$2.28B
Income tax$1.27B$499.00M$508.00M$325.00M$287.00M
Net income$3.25B$2.99B$3.17B$2.36B$1.99B
EBITDA$6.46B$5.12B$5.23B$4.12B$3.86B
EPS (basic)8.497.868.346.235.29
EPS (diluted)8.407.768.256.175.21
Weighted avg. shares (diluted)386.50M385.60M383.70M382.20M382.30M
Balance sheet
Cash & equivalents$4.01B$3.65B$2.97B$1.84B$2.94B
Short-term investments$89.00M$91.00M$82.00M$84.00M$75.00M
Receivables$4.04B$3.99B$3.77B$3.56B$3.02B
Inventory$5.31B$4.77B$4.84B$4.00B$3.31B
Current assets$14.76B$14.85B$12.52B$10.28B$10.02B
PP&E, net$3.88B$3.45B$3.21B$2.97B$2.83B
Goodwill$19.29B$15.86B$15.24B$14.88B$12.92B
Intangibles$5.68B$4.39B$4.59B$4.88B$4.84B
Total assets$47.84B$42.97B$39.91B$36.88B$34.63B
Current liabilities$7.79B$7.62B$7.92B$6.30B$4.55B
Short-term debt$1.00B$1.41B$2.09B$1.19B$7.00M
Long-term debt$14.86B$12.19B$10.90B$11.86B$12.47B
Total debt$15.86B$13.60B$12.99B$13.05B$12.48B
Total liabilities$25.42B$22.34B$21.32B$20.27B$19.75B
Shareholders' equity$22.42B$20.63B$18.59B$16.62B$14.88B
Net debt$11.85B$9.95B$10.02B$11.20B$9.54B
Cash flow statement
Operating cash flow$5.04B$4.24B$3.71B$2.62B$3.26B
Capital expenditure$761.00M$755.00M$575.00M$588.00M$525.00M
Free cash flow$4.28B$3.49B$3.14B$2.04B$2.74B
Investing cash flow-$4.87B-$3.00B-$962.00M-$2.92B-$859.00M
Financing cash flow$113.00M-$525.00M-$1.59B-$749.00M-$2.37B
Depreciation & amortization$1.57B$1.43B$1.34B$1.28B$1.27B
Stock-based compensation$243.00M$229.00M$205.00M$168.00M$171.00M
Dividends paid$1.28B$1.22B$1.14B$1.05B$950.00M
Share buybacks————$0

Free plan shows the latest 5 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.